Myocardial testosterone glucuronide and disease phenotypes in hypertrophic cardiomyopathy
ESC Heart Failure · 2026
DOI: 10.1093/eschf/xvag024 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2026. Verfasst von Takenori Ikoma und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu 431-3192, Japan. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Myocardium, Testosterone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research (C) in Japan, KAKENHI.
Abstract (Originalsprache)
Introduction
The relationship between myocardial lipid metabolism and disease phenotypes, genetic variation, and prognostic factors in patients with hypertrophic cardiomyopathy (HCM) remains largely unexplored. This study aimed to clarify how metabolic remodelling relates to disease phenotypes in HCM. We used desorption electrospray ionization imaging mass spectrometry (DESI-IMS) to compare myocardial lipid signatures in patients who required septal reduction therapy (SRT) and those who did not.
Methods
In this prospective study, patients with HCM undergoing either right-ventricular biopsy or surgical septal myectomy were enrolled. Frozen 10 µm sections were analysed using DESI-IMS, and mass spectra were compared with volcano plots after signal-intensity normalization. Candidate ions showing |log2 fold change| ≥ 1 and P < .05 were annotated using the Human Metabolome Database.
Results
Overall, 61 patients were analysed (34 [55.7%] were female; mean age 64.5 ± 15.9 years). Of these, 43 (70.5%) had obstructive HCM and 20 underwent SRT (SRT, n = 20; non-SRT, n = 41). The SRT group displayed a 3.3-fold higher signal for m/z 463.23, identified as testosterone glucuronide (P < .001). SRT remained the only predictor of elevated testosterone-glucuronide intensity in confirmatory regression (β = 1.991, P = .004), even after adjusting for age at diagnosis and the presence of hypertension, which significantly differed in baseline characteristics between the SRT and non-SRT groups.
Conclusion
DESI-IMS revealed selective accumulation of testosterone glucuronide in hypertrophied myocardium from patients needing SRT, suggesting that androgen-linked metabolic remodelling plays a role in advanced obstructive physiology in HCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu 431-3192, Japan.
- Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Department of Biochemistry and Microbiology, North South University, Dhaka, Bangladesh.
- Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
- Quantum Imaging Laboratory, Division of Research and Development in Photonics Technology and International Mass Imaging and Spatial Omics Center, Institute of Photonics Medicine, Hamamatsu University School of Medicine,…
ORCID-Profile: Takenori Ikoma, Keitaro Akita, Keisuke Iguchi, Kenichiro Suwa, Morimasa Takayama, Tomohiro Iwakura, Hirotomo Saitsu, Mitsutoshi Setou
Förderung
- Scientific Research (C) in Japan
- KAKENHI
Zitieren
APA
Ikoma, T., Akita, K., Ohno, K., Satoh, T., Sato, R., Islam, A., Islam, M. M., Omagari, R., Komatsu, K., Unno, K., Iguchi, K., Suwa, K., Sakamoto, A., Kahyo, T., Takamisawa, I., Takayama, M., Iwakura, T., Takanashi, S., Saitsu, H., …, & Maekawa, Y. (2026). Myocardial testosterone glucuronide and disease phenotypes in hypertrophic cardiomyopathy. ESC Heart Failure. https://doi.org/10.1093/eschf/xvag024
Vancouver
Ikoma T, Akita K, Ohno K, Satoh T, Sato R, Islam A, et al. Myocardial testosterone glucuronide and disease phenotypes in hypertrophic cardiomyopathy. ESC Heart Failure. 2026. doi:10.1093/eschf/xvag024
BibTeX
@article{Ikoma2026,
author = {Ikoma, Takenori and Akita, Keitaro and Ohno, Kazuto and Satoh, Terumori and Sato, Ryota and Islam, Ariful and Islam, Md Monirul and Omagari, Ryo and Komatsu, Kazuyuki and Unno, Kyoko and Iguchi, Keisuke and Suwa, Kenichiro and Sakamoto, Atsushi and Kahyo, Tomoaki and Takamisawa, Itaru and Takayama, Morimasa and Iwakura, Tomohiro and Takanashi, Shuichiro and Saitsu, Hirotomo and Setou, Mitsutoshi and Maekawa, Yuichiro},
title = {Myocardial testosterone glucuronide and disease phenotypes in hypertrophic cardiomyopathy},
journal = {ESC Heart Failure},
year = {2026},
doi = {10.1093/eschf/xvag024}
}
EUVIMED